These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 19688153)
21. Response to valacyclovir in an HIV-infected girl with Epstein Barr infection. Shah I Indian Pediatr; 2012 May; 49(5):409-10. PubMed ID: 22700667 [TBL] [Abstract][Full Text] [Related]
22. Positive Epstein-Barr virus polymerase chain reaction in a case of acute retinal necrosis. Hamam RN; Mansour A; El Mollayess G Can J Ophthalmol; 2012 Dec; 47(6):e61-2. PubMed ID: 23217525 [No Abstract] [Full Text] [Related]
23. Chronic active Epstein-Barr virus infection-associated hydroa vacciniforme-like eruption and Behçet's-like orogenital ulcers. Park BM; Ahn JS; Lee JB; Won YH; Yun SJ Dermatology; 2013; 226(3):212-6. PubMed ID: 23751255 [TBL] [Abstract][Full Text] [Related]
24. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma. Plaza JA; Sangueza M Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933 [TBL] [Abstract][Full Text] [Related]
25. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection. Heo EP; Park SH; Kim TH Int J Dermatol; 2003 Jun; 42(6):476-9. PubMed ID: 12854510 [TBL] [Abstract][Full Text] [Related]
26. Hydroa vacciniforme-like Epstein-Barr virus-associated lymphoproliferative disease: a case report. Zeng Y; Fu L; Jin H; Sun Q; Wang B Pediatr Dermatol; 2012; 29(1):96-100. PubMed ID: 21995788 [TBL] [Abstract][Full Text] [Related]
27. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia. Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477 [TBL] [Abstract][Full Text] [Related]
28. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites. Miyake T; Iwatsuki K; Hirai Y; Yamamoto T; Hamada T; Fujii K; Imamura H; Morizane S J Med Virol; 2020 Dec; 92(12):3689-3696. PubMed ID: 32255500 [TBL] [Abstract][Full Text] [Related]
30. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases. Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684 [TBL] [Abstract][Full Text] [Related]
31. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724 [TBL] [Abstract][Full Text] [Related]
32. [Effect of the Epstein-Barr virus on the nervous system]. Kononenko VV Lik Sprava; 2001; (4):107-11. PubMed ID: 11692687 [TBL] [Abstract][Full Text] [Related]
33. Comparative Study of the Clinical Pathology, Immunophenotype, Epstein-Barr Virus Infection Status, and Gene Rearrangements in Adult and Child Patients With Hydroa Vacciniforme-Like Lymphoproliferative Disorder. Wen PF; Zhang M; Wang TT; Liu HJ; Zhang WY; Liu WP; Wang L Am J Dermatopathol; 2019 Jan; 41(1):7-15. PubMed ID: 30085959 [TBL] [Abstract][Full Text] [Related]
34. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells. Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643 [TBL] [Abstract][Full Text] [Related]
35. Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. Hoshino Y; Katano H; Zou P; Hohman P; Marques A; Tyring SK; Follmann D; Cohen JI J Virol; 2009 Nov; 83(22):11857-61. PubMed ID: 19740997 [TBL] [Abstract][Full Text] [Related]
36. Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi. Olson D; Gulley ML; Tang W; Wokocha C; Mechanic O; Hosseinipour M; Gold SH; Nguluwe N; Mwansambo C; Shores C Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):112-8. PubMed ID: 23260601 [TBL] [Abstract][Full Text] [Related]
37. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients. Xie Y; Wang T; Wang L J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634 [TBL] [Abstract][Full Text] [Related]
38. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. Wang X; Liang Y; Yang Y; Li W; Wang G; Wang S; Li Y; Zhang M J Dermatol; 2021 Sep; 48(9):1315-1326. PubMed ID: 33982815 [TBL] [Abstract][Full Text] [Related]
39. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function. Lerner AM; Beqaj SH; Deeter RG; Dworkin HJ; Zervos M; Chang CH; Fitzgerald JT; Goldstein J; O'Neill W Drugs Today (Barc); 2002 Aug; 38(8):549-61. PubMed ID: 12582420 [TBL] [Abstract][Full Text] [Related]